Neurofibromatosis type 1 and malignancy in childhood

Clinical Genetics

Volumn 89, Issue 3, 2016, Pages 341-345

  Varan, A ^a   Sen H ^a   Aydin, B ^a   Yalcin B ^a   Kutluk, T ^a   Akyuz C ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Brain tumors; Malignant peripheral nerve sheath tumors; Neurofibromatosis; Outcome

Indexed keywords

ADOLESCENT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GLIOMA; HEADACHE; HUMAN; INTRACRANIAL TUMOR; LYMPHOBLASTOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MEDULLOBLASTOMA; NEUROBLASTOMA; NEUROFIBROMATOSIS TYPE 1; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SCHOOL CHILD; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; TREATMENT RESPONSE; TUMOR GROWTH; VOMITING; ADULT; BRAIN NEOPLASMS; COMPLICATION; INFANT; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NERVE SHEATH NEOPLASMS; NEUROBLASTOMA; NEUROFIBROMATOSIS 1; PROGNOSIS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; YOUNG ADULT;

EID: 84958597280     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12625     Document Type: Article

References (28)

1. Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol 2000: 151: 33-40.
2. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol 1995: 75: 136-140.
3. Riccardi VM, Lewis RA. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet 1988: 42: 284-289.
4. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992: 356: 713-715.
5. Yohay K. Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep 2009: 9: 247-253.
6. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986: 314: 1010-1015.
7. Ducatman BS, Scheithauer BW, Piepgras DG et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986: 57: 2006-2021.
8. Friedman JM. Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 2002: 17: 548-554.
9. McKeever K, Shepherd CW, Crawford H, Morrison PJ. An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J 2008: 77: 160-163.
10. Rosser PRT. Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol 2002: 17: 630-637.
11. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010: 12: 1-11.
12. Korf BR. Malignancy in neurofibromatosis type 1. Oncologist 2000: 5: 477-485.
13. Cohen BH, Kaplan AM, Packer RJ. Management of intracranial neoplasms in children with neurofibromatosis type 1 and 2. The Children's Cancer Study Group. Pediatr Neurosurg 1990-1991: 16: 66-72.
14. Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J et al. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst 2010: 26: 1599-1603.
15. Rosenfeld A, Listernick R, Charrow J et al. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst 2010: 26: 663-667.
16. Perilongo FCG, Meadows A, Nowell P et al. Sequential development of wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma, and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report. Leukemia 1993: 7: 912-915.
17. Martinez-Lage SCJ, Poza M. Medulloblastomas in neurofibromatosis type 1. Case report and literature review. Neurocirugia 2002: 13: 128-131.
18. Evans DG, Baser ME, McGaughran J et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002: 39: 311-314.
19. Mautner VF, Friedrich RE, von Deimling A et al. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 2003: 45: 618-625.
20. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002: 62: 1573-1577.
21. Coffin CM, Cassity J, Viskochil D et al. Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Genet A 2004: 127: 40-43.
22. Reich S, Overberg-Schmidt US, Leenen A, Henze G. Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladder. Pediatr Hematol Oncol 1999: 16: 263-266.
23. Lampe AK, Seymour G, Thompson PW et al. Familial neurofibromatosis microdeletion syndrome complicated by rhabdomyosarcoma. Arch Dis Child 2002: 87: 444-445.
24. Sung L, Anderson JR, Arndt C et al. Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Pediatr 2004: 144: 666-668.
25. Papagelopoulos PJ, Mavrogenis AF, Galanis EC et al. Malignant fibrous histiocytoma of bone associated with type-1 neurofibromatosis. A case report. J Bone Joint Surg Am 2005: 87: 399-403.
26. Maris JM, Weiss MJ, Mosse Y. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res 2002: 62: 6651-6658.
27. Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 1994: 70: 969-972.
28. Sharif FRS, Birch J, Gillespie J et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 2006: 24: 2570-2575.